Haleon (NYSE:HLN) Cut to Market Perform at Sanford C. Bernstein

Haleon (NYSE:HLN) was downgraded by investment analysts at Sanford C. Bernstein from an “outperform” rating to a “market perform” rating in a research note issued to investors on Wednesday,Briefing.com Automated Import reports.

Several other equities analysts have also issued reports on the stock. Morgan Stanley lifted their price objective on shares of Haleon from $9.90 to $10.95 and gave the company an “overweight” rating in a report on Friday, September 20th. UBS Group raised Haleon to a “strong-buy” rating in a research report on Tuesday, October 1st. Two analysts have rated the stock with a hold rating, four have issued a buy rating and one has assigned a strong buy rating to the stock. According to MarketBeat.com, the company currently has a consensus rating of “Moderate Buy” and a consensus price target of $10.95.

Haleon Stock Up 0.2 %

NYSE HLN traded up $0.02 during trading on Wednesday, reaching $9.48. 8,515,502 shares of the company’s stock traded hands, compared to its average volume of 6,954,501. Haleon has a 12-month low of $7.89 and a 12-month high of $10.80. The company has a debt-to-equity ratio of 0.44, a current ratio of 0.84 and a quick ratio of 0.58. The firm has a market cap of $42.91 billion, a price-to-earnings ratio of 27.88, a price-to-earnings-growth ratio of 2.95 and a beta of 0.29. The company’s 50 day simple moving average is $9.62 and its two-hundred day simple moving average is $9.67.

Institutional Inflows and Outflows

Institutional investors and hedge funds have recently modified their holdings of the company. FMR LLC increased its position in Haleon by 5.8% during the 3rd quarter. FMR LLC now owns 104,918,269 shares of the company’s stock valued at $1,110,035,000 after buying an additional 5,768,117 shares in the last quarter. Sculptor Capital LP grew its stake in shares of Haleon by 67.8% during the second quarter. Sculptor Capital LP now owns 8,887,098 shares of the company’s stock worth $73,407,000 after acquiring an additional 3,592,000 shares during the last quarter. Clearbridge Investments LLC increased its holdings in shares of Haleon by 8.6% during the second quarter. Clearbridge Investments LLC now owns 41,753,987 shares of the company’s stock valued at $344,888,000 after acquiring an additional 3,307,009 shares in the last quarter. Wellington Management Group LLP raised its position in shares of Haleon by 49.9% in the 3rd quarter. Wellington Management Group LLP now owns 9,152,490 shares of the company’s stock valued at $96,833,000 after purchasing an additional 3,046,841 shares during the last quarter. Finally, JPMorgan Chase & Co. boosted its stake in Haleon by 25.3% in the 3rd quarter. JPMorgan Chase & Co. now owns 5,084,202 shares of the company’s stock worth $53,791,000 after purchasing an additional 1,026,939 shares in the last quarter. Hedge funds and other institutional investors own 6.67% of the company’s stock.

Haleon Company Profile

Haleon plc, together with its subsidiaries, engages in the research, development, manufacture, and sale of various consumer healthcare products in North America, Europe, the Middle East, Africa, Latin America, and the Asia Pacific. The company provides oral health products, such as toothpastes, mouth washes, and denture care products under the Sensodyne, Polident, Parodontax, Biotene brands; and vitamins, minerals, and supplements under Centrum, Emergen-C, Caltrate brands.